Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases

References

• Trougakos IP, Gonos ES. Clusterin/Apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 2002; 34: 1430–1448
   PubMed Web of Science ®Google Scholar
• Calero M, Rostagno A, Frangione B, Ghiso J. Clusterin and Alzheimer's disease. Subcell Biochem 2005; 38: 273–298
   PubMedGoogle Scholar
• Wong P, Taillefer D, Lakins J, Pineault J, Chader G, Tenniswood M. Molecular characterization of human TRPM-2/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration. Eur J Biochem 1994; 221: 917–925
   PubMedGoogle Scholar
• de Silva HV, Harmony JAK, Stuart WD, Gil CM, Robbins J. Apolipoprotein J: Structure and tissue distribution. Biochemistry 1990; 29: 5380–5389
   PubMed Web of Science ®Google Scholar
• Aronow BJ, Lund SD, Brown TL, Harmony JA, Witte DP. Apolipoprotein J expression at fluid-tissue interfaces: Potential role in barrier cytoprotection. Proc Natl Acad Sci USA 1993; 90: 725–729
   PubMed Web of Science ®Google Scholar
• Lakins J, Bennett SA, Chen JH, Arnold JM, Morrissey C, Wong P, O'Sullivan J, Tenniswood M. Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate. J Biol Chem 1998; 273: 27887–27895
   PubMed Web of Science ®Google Scholar
• Kapron JT, Hilliard GM, Lakins JN, Tenniswood MP, West KA, Carr SA, Crabb JW. Identification and characterization of glycosylation sites in human serum clusterin. Protein Sci 1997; 6: 2120–2133
   PubMed Web of Science ®Google Scholar
• Jenne DE, Tschopp J. Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: Identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc Natl Acad Sci USA 1989; 86: 7123–7127
   PubMed Web of Science ®Google Scholar
• Kounnas MZ, Loukinova EB, Stefansson S, Harmony JA, Brewer BH, Strickland DK, Argraves WS. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J Biol Chem 1995; 270: 13070–13075
   PubMed Web of Science ®Google Scholar
• O'Sullivan J, Whyte L, Drake J, Tenniswood M. Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis. Cell Death Differ 2003; 10: 914–927
   PubMed Web of Science ®Google Scholar
• Kang SW, Shin YJ, Shim YJ, Jeong SY, Park IS, Min BH. Clusterin interacts with SCLIP (SCG10-like protein) and promotes neurite outgrowth of PC12 cells. Exp Cell Res 2005; 309: 305–315
   PubMedGoogle Scholar
• Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, Wang CY. Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 2005; 7: 909–915
   PubMed Web of Science ®Google Scholar
• Caccamo AE, Desenzani S, Belloni L, Borghetti AF, Bettuzzi S. Nuclear clusterin accumulation during heat shock response: Implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells. J Cell Physiol 2006; 207: 208–219
   PubMed Web of Science ®Google Scholar
• Wong P, Ulyanova T, Organisciak DT, Bennett S, Lakins J, Arnold JM, Kutty RK, Tenniswood M, vanVeen T, Darrow RM, Chader G. Expression of multiple forms of clusterin during light-induced retinal degeneration. Curr Eye Res 2001; 23: 157–165
   PubMed Web of Science ®Google Scholar
• Kimura K, Yamamoto M. Modification of the alternative splicing process of testosteronerepressed prostate message-2 (TRPM-2) gene by protein synthesis inhibitors and heat shock treatment. Biochim Biophys Acta 1996; 1307: 83–88
   PubMedGoogle Scholar
• Kimura K, Asami K, Yamamoto M. Effect of heat shock treatment on the production of variant testosterone-repressed prostate message-2 (TRPM-2) mRNA in culture cells. Cell Biochem Funct 1997; 15: 251–257
   PubMedGoogle Scholar
• Yang CR, Leskov K, Hosley-Eberlein K, Criswell T, Pink JJ, Kinsella TJ, Boothman DA. Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc Natl Acad Sci USA 2000; 97: 5907–59012
   PubMed Web of Science ®Google Scholar
• Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 2003; 278: 11590–11600
   PubMed Web of Science ®Google Scholar
• Herault Y, Chatelain G, Brun G, Michel D. V-src-inducedtranscription of the avian clusterin gene. Nucleic Acid Res 1992; 20: 6377–6383
   PubMed Web of Science ®Google Scholar
• Jin G, Howe PH. Regulation of clusterin gene expression by transforming growth factor beta. J Biol Chem 1997; 272: 26620–26626
   PubMedGoogle Scholar
• Michel D, Chatelain G, North S, Brun G. Stress-induced transcription of the clusterin/ApoJ gene. Biochem J 1997; 328: 45–50
   PubMed Web of Science ®Google Scholar
• Bailey RW, Dunker AK, Brown CJ, Garner EC, Griswold MD. Clusterin, a binding protein with a molten globule-like region. Biochemistry 2001; 40: 11828–11840
   PubMed Web of Science ®Google Scholar
• Poon S, Easterbrook-Smith SB, Rybchyn MS, Carver JA, Wilson MR. Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. Biochemistry 2000; 39: 15953–15960
   PubMed Web of Science ®Google Scholar
• Lakins JN, Poon S, Easterbrook-Smith SB, Carver JA, Tenniswood MP, Wilson MR. Evidence that clusterin has discrete chaperone and ligand binding sites. Biochemistry 2002; 41: 282–291
   PubMedGoogle Scholar
• Humphreys DT, Carver JA, Easterbrook-Smith SB, Wilson MR. Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem 1999; 274: 6875–6881
   PubMed Web of Science ®Google Scholar
• Wilson MR, Easterbrook-Smith SB. Clusterin is a secreted mammalian chaperone. Trends Biochem Sci 2000; 25: 95–98
   PubMed Web of Science ®Google Scholar
• Bartl MM, Luckenbach T, Bergner O, Ullrich O, Koch-Brandt C. Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes. Exp Cell Res 2001; 271: 130–141
   PubMedGoogle Scholar
• Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng PY, Sawczuk IS. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 1989; 9: 3473–3481
   PubMed Web of Science ®Google Scholar
• de Silva HV, Stuart WD, Duvic CR, Wetterau JR, Ray MJ, Ferguson DG, Albers HW, Smith WR, Harmony JA. A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. J Biol Chem 1990; 265: 13240–13247
   PubMed Web of Science ®Google Scholar
• French LE, Chonn A, Ducrest D, Baumann B, Belin D, Wohlwend A, Kiss JZ, Sappino AP, Tschopp J, Schifferli JA. Murine clusterin: Molecular cloning and mRNA localization of a gene associated with epithelial differentiation processes during embryogenesis. J Cell Biol 1993; 122: 1119–1130
   PubMed Web of Science ®Google Scholar
• O'Bryan MK, Cheema SS, Bartlett PF, Murphy BF, Pearse MJ. Clusterin levels increase during neuronal development. J Neurobiol 1993; 24: 421–432
   PubMedGoogle Scholar
• Ahuja HS, Tenniswood M, Lockshin R, Zakeri ZF. Expression of clusterin in cell differentiation and cell death. Biochem Cell Biol 1994; 72: 523–530
   PubMed Web of Science ®Google Scholar
• Hermo L, Barin K, Oko R. Developmental expression of sulfated glycoprotein-2 in the epididymis of the rat. Anat Rec 1994; 240: 327–344
   PubMedGoogle Scholar
• Silkensen JR, Skubitz KM, Skubitz APN, Chmielewaki DH, Manivel JC, Dvergsten JA, Rosenberg ME. Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells. J Clin Invest 1995; 96: 2646–2653
   PubMedGoogle Scholar
• Silkensen JR, Skubitz KM, Skubitz APN, Rosenberg ME. Identification of Clusterin sequences mediating renal tubular cell interactions. J Pept Res 1999; 54: 449–457
   PubMedGoogle Scholar
• Santilli G, Aronow BJ, Sala A. Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activity. J Biol Chem 2003; 278: 38214–38219
   PubMed Web of Science ®Google Scholar
• Bettuzzi S, Astancolle S, Guidetti G, Moretti M, Tiozzo R, Corti A. Clusterin (SGP-2) gene expression is cell cycle dependent in normal human dermal fibroblasts. FEBS Lett 1999; 448: 297–300
   PubMedGoogle Scholar
• Viard I, Wehrli P, Jornot L, Bullani R, Vechietti JL, Schifferli JA, Tschopp J, French LE. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 1999; 112: 290–296
   PubMed Web of Science ®Google Scholar
• Miyake H, Nelson C, Rennie PS, Gleave ME. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res 2000; 60: 170–176
   PubMed Web of Science ®Google Scholar
• Han BH, DeMattos RB, Dugan LL, Kim-Han JS, Brendza RP, Fryer JD, Kierson M, Cirrito J, Quick K, Harmony JA, Aronow BJ, Holtzman DM. Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat Med 2001; 7: 338–743
   PubMedGoogle Scholar
• Trougakos IP, So A, Jansen B, Gleave ME, Gonos ES. Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability and cell sensitization to genotoxic and oxidative stress. Cancer Res 2004; 64: 1834–1842
   PubMed Web of Science ®Google Scholar
• Trougakos IP, Lourda M, Agiostratidou G, Kletsas D, Gonos ES. Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radic Biol Med 2005; 38: 436–449
   PubMed Web of Science ®Google Scholar
• Matsubara E, Soto C, Governale S, Frangione B, Ghiso J. Apolipoprotein J and Alzheimer's amyloid beta solubility. Biochem J 1996; 316: 671–679
   PubMed Web of Science ®Google Scholar
• Ghiso J, Matsubara E, Koudinov A, Choi-Miura NH, Tomita M, Wisniewski T, Frangione B. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J 1993; 293: 27–30
   PubMed Web of Science ®Google Scholar
• Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W, Reichrath J. Challenge and promise: Roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 2006; 13: 12–19
   PubMed Web of Science ®Google Scholar
• Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547–581
   PubMed Web of Science ®Google Scholar
• Martindale JL, Holbrook NJ. Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 2002; 192: 1–15
   PubMed Web of Science ®Google Scholar
• Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266: 37–56
   PubMed Web of Science ®Google Scholar
• Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005; 10: 1881–1896
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160: 1–40
   PubMed Web of Science ®Google Scholar
• Yu BP, Chung HY. Adaptive mechanisms to oxidative stress during aging. Mech Ageing Dev 2006; 127: 436–443
   PubMed Web of Science ®Google Scholar
• Carrard G, Bulteau AL, Petropoulos I, Friguet B. Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 2002; 34: 1461–1474
   PubMed Web of Science ®Google Scholar
• Chondrogianni N, Gonos ES. Proteasome dysfunction in mammalian aging: Steps and factors involved. Exp Gerontol 2005; 40: 931–938
   PubMed Web of Science ®Google Scholar
• Poppek D, Grune T. Proteasomal defense of oxidative protein modifications. Antioxid Redox Signal 2006; 8: 173–184
   PubMed Web of Science ®Google Scholar
• Floyd RA, West MS, Eneff KL, Schneider JE, Wong PK, Tingey DT, Hogsett WE. Conditions influencing yield and analysis of 8-hydroxy-2′-deoxyguanosine in oxidatively damaged DNA. Anal Biochem 1990; 188: 155–158
   PubMed Web of Science ®Google Scholar
• Mariani E, Polidori MC, Cherubini A, Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 827: 65–75
   PubMed Web of Science ®Google Scholar
• Morimoto RI. Dynamic remodeling of transcription complexes by molecular chaperones. Cell 2002; 110: 281–284
   PubMedGoogle Scholar
• Soti C, Pal C, Papp B, Csermely P. Molecular chaperones as regulatory elements of cellular networks. Curr Opin Cell Biol 2005; 17: 210–215
   PubMed Web of Science ®Google Scholar
• Shackelford RE, Kaufmann WK, Paules RS. Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 2000; 28: 1387–1404
   PubMed Web of Science ®Google Scholar
• Graf PC, Jakob U. Redox-regulated molecular chaperones. Cell Mol Life Sci 2002; 59: 1624–16231
   PubMedGoogle Scholar
• Kirkwood TB. Evolution of ageing. Mech Ageing Dev 2002; 123: 737–745
   PubMed Web of Science ®Google Scholar
• Holliday R. Causes of aging. Ann NY Acad Sci 1998; 854: 61–71
   PubMedGoogle Scholar
• Trougakos IP, Chondrogianni N, Pimenidou A, Katsiki M, Tzavelas C, Gonos ES. Slowing down cellular aging in vitro. Modulating aging and longevity, SI Rattan. Kluwer Academic Publishers, The Netherlands 2002; 65–83
   Google Scholar
• Lane N. A unifying view of ageing and disease: The double-agent theory. J Theor Biol 2003; 225: 531–540
   PubMed Web of Science ®Google Scholar
• Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408: 239–247
   PubMed Web of Science ®Google Scholar
• Golden TR, Hinerfeld DA, Melov S. Oxidative stress and aging: Beyond correlation. Aging Cell 2002; 2: 117–123
   Google Scholar
• Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47–95
   PubMed Web of Science ®Google Scholar
• Campisi J. Cancer and ageing: Rival demons?. Nat Rev Cancer 2003; 3: 339–349
   PubMed Web of Science ®Google Scholar
• Grune T, Jung T, Merker K, Davies KJ. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and “aggresomes” during oxidative stress, aging, and disease. Int J Biochem Cell Biol 2004; 36: 2519–2530
   PubMed Web of Science ®Google Scholar
• Hekimi S, Guarente L. Genetics and the specificity of the aging process. Science 2003; 299: 1351–1354
   PubMed Web of Science ®Google Scholar
• Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, Pelicci PG. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999; 402: 309–313
   PubMed Web of Science ®Google Scholar
• Migliaccio E, Giorgio M, Pelicci PG. Apoptosis and aging: Role of p66(Shc) redox protein. Antioxid Redox Signal 2006; 8: 600–608
   PubMed Web of Science ®Google Scholar
• Sagi O, Wolfson M, Utko N, Muradian K, Fraifeld V. p66ShcA and ageing: Modulation by longevity-promoting agent aurintricarboxylic acid. Mech Ageing Dev 2005; 126: 249–254
   PubMedGoogle Scholar
• Francia P, delli Gatti C, Bachschmid M, Martin-Padura I, Savoia C, Migliaccio E, Pelicci PG, Schiavoni M, Luscher TF, Volpe M, Cosentino F. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation 2004; 110: 2889–2895
   PubMed Web of Science ®Google Scholar
• Campisi J. Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell 2005; 120: 513–522
   PubMed Web of Science ®Google Scholar
• Collado M, Serrano M. Innovation: The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 2006; 6: 472–476
   PubMed Web of Science ®Google Scholar
• Friguet B, Bulteau AL, Conconi M, Petropoulos I. Redox control of 20S proteasome. Methods Enzymol 2002; 353: 253–262
   PubMedGoogle Scholar
• Loft S, Deng XS, Tuo J, Wellejus A, Sorensen M, Poulsen HE. Experimental study of oxidative DNA damage. Free Radic Res 1998; 29: 525–539
   PubMed Web of Science ®Google Scholar
• Stocker R, Keaney JF, Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381–1478
   PubMed Web of Science ®Google Scholar
• Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997; 96: 2414–2420
   PubMed Web of Science ®Google Scholar
• Li RK, Sole MJ, Mickle DA, Schimmer J, Goldstein D. Vitamin E and oxidative stress in the heart of the cardiomyopathic syrian hamster. Free Radic Biol Med 1998; 24: 252–258
   PubMedGoogle Scholar
• Barja G. Free radicals and aging. Trends Neurosci 2004; 27: 595–600
   PubMed Web of Science ®Google Scholar
• Alexandrova M, Bochev P, Markova V, Bechev B, Popova M, Danovska M, Simeonova V. Dynamics of free radical processes in acute ischemic stroke: Influence on neurological status and outcome. J Clin Neurosci 2004; 11: 501–506
   PubMed Web of Science ®Google Scholar
• Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 2003; 53: S26–S36
   PubMed Web of Science ®Google Scholar
• Honda K, Casadesus G, Petersen RB, Perry G, Smith MA. Oxidative stress and redoxactive iron in Alzheimer's disease. Ann NY Acad Sci 2004; 1012: 179–182
   PubMed Web of Science ®Google Scholar
• Zhu X, Raina AK, Perry G, Smith MA. Alzheimer's disease: The two-hit hypothesis. Lancet Neurol 2004; 3: 219–226
   PubMed Web of Science ®Google Scholar
• Dyrks T, Dyrks E, Masters CL, Beyreuther K. Amyloidogenicity of rodent and human beta A4 sequences. FEBS Lett 1993; 324: 231–236
   PubMed Web of Science ®Google Scholar
• Troncoso JC, Costello A, Watson AL, Jr, Johnson GV. In vitro polymerization of oxidized tau into filaments. Brain Res 1993; 613: 313–316
   PubMedGoogle Scholar
• Bellomo G, Mirabelli F. Oxidative stress and cytoskeletal alterations. Ann NY Acad Sci 1992; 663: 97–109
   PubMedGoogle Scholar
• Frippiat C, Chen QM, Zdanov S, Magalhaes JP, Remacle J, Toussaint O. Subcytotoxic H2O2 stress triggers a release of transforming growth factor-β1 which induces biomarkers of cellular senescence in human diploid fibroblasts. J Biol Chem 2001; 276: 2531–2537
   PubMed Web of Science ®Google Scholar
• Criswell T, Beman M, Araki S, Leskov K, Cataldo E, Mayo LD, Boothman DA. Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor. J Biol Chem 2005; 280: 14212–14221
   PubMed Web of Science ®Google Scholar
• Chondrogianni N, Stratford FLL, Trougakos IP, Friguet B, Rivett AJ, Gonos ES. Central role of the proteasome in senescence and survival of human fibroblasts: Induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J Biol Chem 2003; 278: 28026–28037
   PubMed Web of Science ®Google Scholar
• Loison F, Debure L, Nizard P, le Goff P, Michel D, le Drean Y. Up-regulation of the clusterin gene after proteotoxic stress: Implication of HSF1–HSF2 heterocomplexes. Biochem J 2006; 395: 223–231
   PubMed Web of Science ®Google Scholar
• Dumont P, Chainiaux F, Eliaers F, Petropoulou C, Remacle J, Koch-Brandt C, Gonos ES, Toussaint O. Overexpression of apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induced by ethanol and tert-butylhydroperoxide. Cell Stress Chaperones 2002; 7: 23–35
   PubMed Web of Science ®Google Scholar
• Miyake H, Hara I, Gleave ME, Eto H. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen. Prostate 2004; 61: 318–323
   PubMed Web of Science ®Google Scholar
• Carnevali S, Luppi F, D'Arca D, Caporali A, Ruggieri MP, Vettori MV, Caglieri A, Astancolle S, Panico F, Davalli P, Mutti A, Fabbri LM, Corti A. Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke. Am J Respir Crit Care Med 2006, Epub ahead of print
   PubMedGoogle Scholar
• Scaltriti M, Bettuzzi S, Sharrard RM, Caporali A, Caccamo AE, Maitland NJ. Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis. Br J Cancer 2004; 91: 1842–1850
   PubMed Web of Science ®Google Scholar
• Scaltriti M, Santamaria A, Paciucci R, Bettuzzi S. Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1. Cancer Res 2004; 64: 6174–6182
   PubMed Web of Science ®Google Scholar
• Thomas-Tikhonenko A, Viard-Leveugle I, Dews M, Wehrli P, Sevignani C, Yu D, Ricci S, el-Deiry W, Aronow B, Kaya G, Saurat JH, French LE. Myc-transformed epithelial cells downregulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo. Cancer Res 2004; 64: 3126–3136
   PubMed Web of Science ®Google Scholar
• Gonos ES, Derventzi A, Kveiborg M, Agiostratidou G, Kassem M, Clark BFC, Jat PS, Rattan SIS. Cloning and identification of genes that associate with mammalian senescence. Exp Cell Res 1998; 240: 66–74
   PubMed Web of Science ®Google Scholar
• Petropoulou C, Trougakos IP, Kolettas E, Toussaint O, Gonos ES. Clusterin/apolipoprotein J is a novel biomarker of cellular senescence, that does not affect the proliferative capacity of human diploid fibroblasts. FEBS Lett 2001; 509: 287–297
   PubMed Web of Science ®Google Scholar
• Debacq-Chainiaux F, Borlon C, Pascal T, Royer V, Eliaers F, Ninane N, Carrard G, Friguet B, de Longueville F, Boffe S, Remacle J, Toussaint O. Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGFbeta1 signaling pathway. J Cell Sci 2005; 118: 743–758
   PubMedGoogle Scholar
• Dumont P, Burton M, Chen QM, Gonos ES, Frippiat C, Mazarati JB, Eliaers F, Remacle J, Toussaint O. Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Radic Biol Med 2000; 28: 361–373
   PubMed Web of Science ®Google Scholar
• Katsiki M, Trougakos IP, Chondrogianni N, Alexopoulos EC, Makropoulos V, Gonos ES. Alterations of senescence biomarkers in human cells by exposure to CrVI in vivo and in vitro. Exp Gerontol 2004; 39: 1079–1087
   PubMedGoogle Scholar
• Kalka K, Ahmad N, Criswell T, Boothman D, Mukhtar H. Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy-mediated apoptosis of tumor cells and ablation of mouse skin tumors. Cancer Res 2000; 60: 5984–5987
   PubMed Web of Science ®Google Scholar
• Chen T, Turner J, McCarthy S, Scaltriti M, Bettuzzi S, Yeatman TJ. Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent. Cancer Res 2004; 64: 7412–7419
   PubMed Web of Science ®Google Scholar
• Caccamo AE, Scaltriti M, Caporali A, D'Arca D, Corti A, Corvetta D, Sala A, Bettuzzi S. Ca2+ depletion induces nuclear clusterin, a novel effector of apoptosis in immortalized human prostate cells. Cell Death Differ 2005; 12: 101–104
   PubMed Web of Science ®Google Scholar
• Debure L, Vayssiere JL, Rincheval V, Loison F, Le Drean Y, Michel D. Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration. J Cell Sci 2003; 116: 3109–31021
   PubMedGoogle Scholar
• Miyake H, Nelson C, Rennie PS, Gleave ME. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res 2000; 60: 2547–2554
   PubMed Web of Science ®Google Scholar
• Zellweger T, Kiyama S, Chi K, Miyake H, Adomat H, Skov K, Gleave ME. Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model. BJU Int 2003; 92: 463–469
   PubMed Web of Science ®Google Scholar
• Hoeller C, Pratscher B, Thallinger C, Winter D, Fink D, Kovacic B, Sexl V, Wacheck V, Gleave ME, Pehamberger H, Jansen B. Clusterin regulates drug-resistance in melanoma cells. J Invest Dermatol 2005; 124: 1300–1307
   PubMed Web of Science ®Google Scholar
• Xie D, Sham JS, Zeng WF, Che LH, Zhang M, Wu HX, Lin HL, Wen JM, Lau SH, Hu L, Guan XY. Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression. World J Gastroenterol 2005; 11: 3285–3289
   PubMed Web of Science ®Google Scholar
• Wehrli P, Charnay Y, Vallet P, Zhu G, Harmony J, Aronow B, Tschopp J, Bouras C, Viard-Leveugle I, French LE, Giannakopoulos P. Inhibition of post-ischemic brain injury by clusterin overexpression. Nat Med 2001; 7: 977–978
   PubMed Web of Science ®Google Scholar
• McLaughlin L, Zhu G, Mistry M, Ley-Ebert C, Stuart WD, Florio CJ, Groen PA, Witt SA, Kimball TR, Witte DP, Harmony JA, Aronow BJ. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest 2000; 106: 1105–1113
   PubMed Web of Science ®Google Scholar
• Rosenberg ME, Girton R, Finkel D, Chmielewski D, Barrie A, 3rd, Witte DP, Zhu G, Bissler JJ, Harmony JA, Aronow BJ. Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging. Mol Cell Biol 2002; 22: 1893–1902
   PubMed Web of Science ®Google Scholar
• Bailey RW, Aronow B, Harmony JA, Griswold MD. Heat shock-initiated apoptosis is accelerated and removal of damaged cells is delayed in the testis of clusterin/ApoJ knock-out mice. Biol Reprod 2002; 66: 1042–1053
   PubMed Web of Science ®Google Scholar
• Miyake H, Chi KN, Gleave ME. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo. Clin Cancer Res 2000; 6: 1655–1663
   PubMed Web of Science ®Google Scholar
• Patterson SG, Wei S, Chen X, Sallman DA, Gilvary DL, Zhong B, Pow-Sang J, Yeatman T, Djeu JY. Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells. Oncogene 2006, [Epub ahead of print]
   PubMedGoogle Scholar
• Chi KN, Eisenhauer E, Fazli L, Jones EC, Goldenberg SL, Powers J, Tu D, Gleave ME. A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2′-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer. J Natl Cancer Inst 2005; 97: 1287–1296
   PubMed Web of Science ®Google Scholar
• Miyake H, Hara I, Gleave ME. Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic. Int J Urol 2005; 12: 785–794
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Zhu BL, Li DR, Zhao D, Michiue T, Maeda H. Age-dependent increase of clusterin in the human pituitary gland. Leg Med (Tokyo) 2006; 8: 28–33
   PubMedGoogle Scholar
• Lau KM, Tam NN, Thompson C, Cheng RY, Leung YK, Ho SM. Age-associated changes in histology and gene-expression profile in the rat ventral prostate. Lab Invest 2003; 83: 743–757
   PubMedGoogle Scholar
• Patel NV, Wei M, Wong A, Finch CE, Morgan TE. Progressive changes in regulation of apolipoproteins E and J in glial cultures during postnatal development and aging. Neurosci Lett 2004; 371: 199–204
   PubMedGoogle Scholar
• Trougakos IP, Petropoulou C, Franceschi C, Gonos ES. Reduced expression levels of the senescence biomarker clusterin/apolipoprotein J in lymphocytes from healthy centenarians. Ann NY Acad Sci 2006; 1067: 294–300
   PubMed Web of Science ®Google Scholar
• Trougakos IP, Poulakou M, Stathatos M, Chalikia A, Melidonis A, Gonos ES. Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction. Exp Gerontol 2002; 37: 1175–1187
   PubMed Web of Science ®Google Scholar
• Scaltriti M, Brausi M, Amorosi A, Caporali A, D'Arca D, Astancolle S, Corti A, Bettuzzi S. Clusterin (SGP-2, APOJ) expression is downregulated in low- and high-grade human prostate cancer. Int J Cancer 2004; 108: 23–30
   PubMed Web of Science ®Google Scholar
• Zhang LY, Ying WT, Mao YS, He HZ, Liu Y, Wang HX, Liu F, Wang K, Zha XH. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of oesophageal squamous cell carcinoma via proteomic approaches. World J Gastroenterol 2003; 9: 650–654
   PubMed Web of Science ®Google Scholar
• Saffer H, Wahed A, Rassidakis GZ, Medeiros LJ. Clusterin expression in malignant lymphomas. Mod Pathol 2002; 15: 1221–1223
   PubMedGoogle Scholar
• Redondo M, Villar E, Torres-Munoz J, Tellez T, Morell M, Petito CK. Overexpression of clusterin in human breast carcinoma. Am J Pathol 2002; 157: 393–399
   Google Scholar
• Chen X, Halberg RB, Ehrhardt WM, Torrealba J, Dover WF. Clusterin as a biomarker in murine and human intestinal neoplasia. Proc Natl Acad Sci USA 2003; 100: 9530–9535
   PubMed Web of Science ®Google Scholar
• Pucci S, Bonanno E, Pichiorri F, Angeloni C, Spagnoli LG. Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 2004; 23: 2298–2304
   PubMed Web of Science ®Google Scholar
• Kang YK, Hong SW, Lee H, Kim WH. Overexpression of clusterin in human hepatocellular carcinoma. Hum Pathol 2004; 35: 1340–1346
   PubMed Web of Science ®Google Scholar
• Lau SH, Sham JS, Xie D, Tzang CH, Tang D, Ma N, Hu L, Wang Y, Wen JM, Xiao G, Zhang WM, Lau GK, Yang M, Guan XY. Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene 2006; 25: 1242–1250
   PubMed Web of Science ®Google Scholar
• Klock G, Storch S, Rickert J, Gutacker C, Koch-Brandt C. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis. J Cell Physiol 1998; 177: 593–605
   PubMed Web of Science ®Google Scholar
• Lund P, Weisshaupt K, Mikeska T, Jammas D, Chen X, Kuban RJ, Ungethum U, Krapfenbauer U, Herzel HP, Schafer R, Walter J, Sers C, Oncogenic HRAS. suppresses clusterin expression through promoter hypermethylation. Oncogene 2006, [Epub ahead of print]
   PubMedGoogle Scholar
• Mackness B, Hunt R, Durrington PN, Mackness MI. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 1233–1338
   PubMed Web of Science ®Google Scholar
• Krijnen PA, Cillessen SA, Manoe R, Muller A, Visser CA, Meijer CJ, Musters RJ, Hack CE, Aarden LA, Niessen HW. Clusterin: A protective mediator for ischemic cardiomyocytes?. Am J Physiol Heart Circ Physiol 2005; 289: H2193–H2202
   PubMedGoogle Scholar
• Oda T, Pasinetti GM, Osterburg HH, Anderson C, Johnson SA, Finch CE. Purification and characterization of brain clusterin. Biochem Biophys Res Commun 1994; 204: 1131–1136
   PubMed Web of Science ®Google Scholar
• Kida E, Choi-Miura NH, Wisniewski KE. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain. Brain Res 1995; 685: 211–216
   PubMedGoogle Scholar
• McHattie S, Edington N. Clusterin prevents aggregation of neuropeptide 106–126 in vitro. Biochem Biophys Res Commun 1999; 259: 336–340
   PubMedGoogle Scholar
• Boggs LN, Fuson KS, Baez M, Churgay L, McClure D, Becker G, May PC. Clusterin (Apo J) protects against in vitro amyloid-beta(1–40) neurotoxicity. J Neurochem 1996; 67: 1324–1327
   PubMed Web of Science ®Google Scholar
• Oda T, Wals P, Osterburg HH, Johnson SA, Pasinetti GM, Morgan TE, Rozovsky I, Stine WB, Snyder SW, Holzman TF, Krafft GA, Finch CE. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (Abeta 1–42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp Neurol 1995; 136: 22–31
   PubMed Web of Science ®Google Scholar
• Choi-Miura NH, Oda T. Relationship between multifunctional protein “clusterin” and Alzheimer disease. Neurobiol Aging 1996; 17: 717–722
   PubMed Web of Science ®Google Scholar
• DeMattos RB, O'dell MA, Parsadanian M, Taylor JW, Harmony JAK, Bales KR, Paul SM, Aronow BJ, Holtzman DM. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2002; 99: 10843–10848
   PubMed Web of Science ®Google Scholar
• Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 1997; 17: 263–264
   PubMed Web of Science ®Google Scholar
• Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, Fishman CE, DeLong CA, Piccardo P, Petegnief V, Ghetti B, Paul SM. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 1999; 96: 15233–15238
   PubMed Web of Science ®Google Scholar
• DeMattos RB, Cirrito JR, Parsadanian M, May PC, O'Dell MA, Taylor JW, Harmony JA, Aronow BJ, Bales KR, Paul SM, Holtzman DM. ApoE and clusterin cooperatively suppress Abeta levels and deposition. Evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 2004; 41: 193–202
   PubMed Web of Science ®Google Scholar
• Franceschi C, Bonafe M. Centenarians as a model for healthy aging. Biochem Soc Trans 2003; 31: 457–4561
   PubMed Web of Science ®Google Scholar
• Sun Y, MacRae TH. Small heat shock proteins: Molecular structure and chaperone function. Cell Mol Life Sci 2005; 62: 2460–2476
   PubMed Web of Science ®Google Scholar
• Kamradt MC, Chen F, Sam S, Cryns VL. The small heat shock protein aB-crystallin negatively regulates apoptosis during mitogenic differentiation by inhibiting caspase-3 activation. J Biol Chem 2002; 277: 38731–38736
   PubMedGoogle Scholar
• Concannon CG, Gorman AM, Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis 2003; 8: 61–70
   PubMed Web of Science ®Google Scholar
• Soti C, Csermely P. Aging and molecular chaperones. Exp Gerontol 2003; 38: 1037–1040
   PubMedGoogle Scholar
• Tetu B, Lacasse B, Bouchard HL, Lagace R, Huot J, Landry J. Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: A clinicopathological and immunohistochemical study. Cancer Res 1992; 52: 2325–2328
   PubMedGoogle Scholar
• Aoyama A, Steiger RH, Frohli E, Schafer R, von Deimling A, Wiestler OD, Klemenz R. Expression of aB-crystallin in human brain tumors. Int J Cancer 1993; 55: 760–764
   PubMed Web of Science ®Google Scholar
• Ungar DR, Hailat N, Strahler JR, Kuick RD, Brodeur GM, Seeger RC, Reynolds CP, Hanash SM. Hsp27 expression in neuroblastoma: Correlation with disease stage. J Natl Cancer Inst 1994; 86: 780–784
   PubMedGoogle Scholar
• Aldrian S, Trautinger F, Frohlich I, Berger W, Micksche M, Kindas-Mugge I. Overexpression of Hsp27 affects the metastatic phenotype of human melanoma cells in vitro. Cell Stress Chaperones 2002; 7: 177–185
   PubMed Web of Science ®Google Scholar
• Elpek GO, Karaveli S, Simsek T, Keles N, Aksoy NH. Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries. APMIS 2003; 111: 523–530
   PubMed Web of Science ®Google Scholar
• Chelouche-Lev D, Kluger HM, Berger AJ, Rimm DL, Price JE. aB-crystallin as a marker of lymph node involvement in breast carcinoma. Cancer 2004; 100: 2543–2548
   PubMedGoogle Scholar
• Martin JL, Mestril R, Hilal-Dandan R, Brunton LL, Dillmann WH. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 1997; 96: 4343–4348
   PubMed Web of Science ®Google Scholar
• Ray PS, Martin JL, Swanson EA, Otani H, Dillmann WH, Das DK. Transgene overexpression of aB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J 2001; 15: 393–402
   PubMed Web of Science ®Google Scholar
• Hollander JM, Martin JL, Belke DD, Scott BT, Swanson E, Krishnamoorthy V, Dillmann WH. Overexpression of wild-type heat shock protein 27 and a nonphosphorylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model. Circulation 2004; 110: 3544–3552
   PubMed Web of Science ®Google Scholar
• Shinohara H, Inaguma Y, Goto S, Inagaki T, Kato K. aB crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J Neurol Sci 1993; 119: 203–208
   PubMedGoogle Scholar
• Renkawek K, Voorter CE, Bosman GJ, van Workum FP, de Jong WW. Expression of aBcrystallin in Alzheimer's disease. Acta Neuropathol (Berl) 1994; 87: 155–160
   PubMedGoogle Scholar
• Yoo BC, Kim SH, Cairns N, Fountoulakis M, Lubec G. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 2001; 280: 249–258
   PubMed Web of Science ®Google Scholar
• Sun Y, MacRae TH. The small heat shock proteins and their role in human disease. FEBS J 2005; 272: 2613–2627
   PubMed Web of Science ®Google Scholar